Table of Contents
Pain Research and Treatment
Volume 2011, Article ID 647967, 13 pages
http://dx.doi.org/10.1155/2011/647967
Review Article

Repeated Muscle Injury as a Presumptive Trigger for Chronic Masticatory Muscle Pain

1Department of Neural and Pain Sciences, University of Maryland, 650 West Baltimore Street, Baltimore, MD 21201, USA
2Graduate Program in Life Sciences, University of Maryland, 650 West Baltimore Street, Baltimore, MD 21201, USA
3Department of Orthopaedics, University of Maryland, 20 Penn Street, Baltimore, MD 21201, USA

Received 31 January 2011; Accepted 14 April 2011

Academic Editor: Cyril Rivat

Copyright © 2011 Dean Dessem and Richard M. Lovering. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Magni, C. Caldieron, S. Rigatti-Luchini, and H. Merskey, “Chronic muscoskeletal pain and depressive symptoms in the general population. An analysis of the 1st National Health and Nutrition Examination Survey data,” Pain, vol. 43, no. 3, pp. 299–307, 1990. View at Publisher · View at Google Scholar · View at Scopus
  2. T. G. Kantor, “The pharmacological control of musculoskeletal pain,” Canadian Journal of Physiology and Pharmacology, vol. 69, no. 5, pp. 713–718, 1991. View at Google Scholar · View at Scopus
  3. L. Jacobson, A. J. Mariano, C. Chabal, E. F. Chancy, and C. Mar, “What is adequate and appropriate pain treatment?” Journal of the American Medical Association, vol. 275, no. 17, pp. 1310–1311, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. C. McNeill, N. D. Mohl, J. D. Rugh, and T. T. Tanaka, “Temporomandibular disorders: diagnosis, management, education, and research,” The Journal of the American Dental Association, vol. 120, no. 3, pp. 253–257, 1990. View at Google Scholar · View at Scopus
  5. G. T. Clark, “Treatment of myogenous pain and dysfunction,” in TMDs: An Evidence-Based Approach to Diagnosis and Treatment, D. M. Laskin, C. S. Greene, and W. L. Hylander, Eds., pp. 483–500, Quintenssence Publishing Co., Chicago, Ill, USA, 2006. View at Google Scholar
  6. J. Epker, R. J. Gatchel, and E. Ellis, “A model for predicting chronic TMD: practical application in clinical settings,” Journal of the American Dental Association, vol. 130, no. 10, pp. 1470–1475, 1999. View at Google Scholar · View at Scopus
  7. L. P. S. Machado, C. G. Nery, C. R. Leles, M. B. M. Nery, and J. P. Okeson, “The prevalence of clinical diagnostic groups in patients with temporomandibular disorders,” Cranio, vol. 27, no. 3, pp. 194–199, 2009. View at Google Scholar · View at Scopus
  8. S. F. Dworkin and L. LeResche, “Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique,” Journal of Craniomandibular Disorders, vol. 6, no. 4, pp. 301–355, 1992. View at Google Scholar · View at Scopus
  9. C. S. Stohler, “Muscle-related temporomandibular disorders,” Journal of Orofacial Pain, vol. 13, no. 4, pp. 273–284, 1999. View at Google Scholar · View at Scopus
  10. O. Plesh, F. Wolfe, and N. Lane, “The relationship between fibromyalgia and temporomandibular disorders: prevalence and symptom severity,” Journal of Rheumatology, vol. 23, no. 11, pp. 1948–1952, 1996. View at Google Scholar · View at Scopus
  11. B. Hedenberg-Magnusson, M. Ernberg, and S. Kopp, “Symptoms and signs of temporomandibular disorders in patients with fibromyalgia and local myalgia of the temporomandibular system: a comparative study,” Acta Odontologica Scandinavica, vol. 55, no. 6, pp. 344–349, 1997. View at Google Scholar · View at Scopus
  12. O. Plesh and S. Gansky, “Fibromyalgia,” in TMDs: An Evidence-Based Approach to Diagnosis and Treatment, D. Laskin, C. Green, and W. Hylander, Eds., pp. 335–345, Quintenssence Publishing, Chicago, Ill, USA, 2006. View at Google Scholar
  13. F. Wolfe, K. Ross, J. Anderson, I. J. Russell, and L. Hebert, “The prevalence and characteristics of fibromyalgia in the general population,” Arthritis and Rheumatism, vol. 38, no. 1, pp. 19–28, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. S. A. McLean and D. J. Clauw, “Biomedical models of fibromyalgia,” Disability and Rehabilitation, vol. 27, no. 12, pp. 659–665, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. C. G. Widmer, “Idiopathic masticatory muscle pain,” Pain Forum, vol. 6, pp. 170–172, 1997. View at Google Scholar
  16. F. Wolfe, R. S. Katz, and K. Michaud, “Jaw pain: its prevalence and meaning in patients with rheumatoid arthritis, osteoarthritis, and fibromyalgia,” Journal of Rheumatology, vol. 32, no. 12, pp. 2421–2428, 2005. View at Google Scholar · View at Scopus
  17. S. Mense, “Nociception from skeletal muscle in relation to clinical muscle pain,” Pain, vol. 54, no. 3, pp. 241–289, 1993. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Mense and D. Simons, Muscle Pain, Understanding Its Nature, Diagnosis and Treatment, Lippincott Williams & Wilkins, Baltimore, Md, USA, 2000.
  19. M. Curatolo and N. Bogduk, “Pharmacologic pain treatment of musculoskeletal disorders: current perspectives and future prospects,” Clinical Journal of Pain, vol. 7, no. 1, pp. 25–32, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. S. G. Smith, “Dangers of NSAIDs in the elderly,” Canadian Family Physician, vol. 35, pp. 653–654, 1989. View at Google Scholar
  21. M. R. Tramèr, R. A. Moore, D. J. M. Reynolds, and H. J. McQuay, “Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use,” Pain, vol. 85, no. 1-2, pp. 169–182, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. A. E. Donnelly, R. J. Maughan, and P. H. Whiting, “Effects of ibuprofen on exercise-induced muscle soreness and indices of muscle damage,” British Journal of Sports Medicine, vol. 24, no. 3, pp. 191–195, 1990. View at Google Scholar · View at Scopus
  23. L. C. Loram, D. Mitchell, and A. Fuller, “Rofecoxib and tramadol do not attenuate delayed-onset muscle soreness or ischaemic pain in human volunteers,” Canadian Journal of Physiology and Pharmacology, vol. 83, no. 12, pp. 1137–1145, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. J. A. Mitchell, R. Lucas, I. Vojnovic, K. Hasan, J. R. Pepper, and T. D. Warner, “Stronger inhibition by nonsteroid anti-inflammatory drugs of cyclooxygenase-1 in endothelial cells than platelets offers an explanation for increased risk of thrombotic events,” FASEB Journal, vol. 20, no. 14, pp. 2468–2475, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. E. E. Castrillon, B. E. Cairns, M. Ernberg et al., “Effect of a peripheral NMDA receptor antagonist on glutamate-evoked masseter muscle pain and mechanical sensitization in women,” Journal of Orofacial Pain, vol. 21, no. 3, pp. 216–224, 2007. View at Google Scholar · View at Scopus
  26. P. Barlas, J. A. Craig, J. Robinson, D. M. Walsh, G. D. Baxter, and J. M. Allen, “Managing delayed-onset muscle soreness: lack of effect of selected oral systemic analgesics,” Archives of Physical Medicine and Rehabilitation, vol. 81, no. 7, pp. 966–972, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. R. N. Jamison, S. A. Raymond, E. A. Slawsby, S. S. Nedeljkovic, and N. P. Katz, “Opioid therapy for chronic noncancer back pain: a randomized prospective study,” Spine, vol. 23, no. 23, pp. 2591–2600, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. C. A. Ray and J. R. Carter, “Central modulation of exercise-induced muscle pain in humans,” Journal of Physiology, vol. 585, no. 1, pp. 287–294, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. R. Benyamin, A. M. Trescot, S. Datta et al., “Opioid complications and side effects,” Pain Physician, vol. 11, supplement 2, pp. S105–S120, 2008. View at Google Scholar · View at Scopus
  30. W. Maixner, R. Fillingim, A. Sigurdsson, S. Kincaid, and S. Silva, “Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain: evidence for altered temporal summation of pain,” Pain, vol. 76, no. 1-2, pp. 71–81, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. J. A. Desmeules, C. Cedraschi, E. Rapiti et al., “Neurophysiologic evidence for a central sensitization in patients with fibromyalgia,” Arthritis and Rheumatism, vol. 48, no. 5, pp. 1420–1429, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. E. Sarlani, E. G. Grace, M. A. Reynolds, and J. D. Greenspan, “Evidence for up-regulated central nociceptive processing in patients with masticatory myofascial pain,” Journal of Orofacial Pain, vol. 18, no. 1, pp. 41–55, 2004. View at Google Scholar · View at Scopus
  33. R. Staud, M. E. Robinson, and D. D. Price, “Isometric exercise has opposite effects on central pain mechanisms in fibromyalgia patients compared to normal controls,” Pain, vol. 118, no. 1-2, pp. 176–184, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. C. J. Vierck Jr., “Mechanisms underlying development of spatially distributed chronic pain (fibromyalgia),” Pain, vol. 124, no. 3, pp. 242–263, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. P. D. Wall and C. J. Woolf, “Muscle but not cutaneous C-afferent input produces prolonged increases in the excitability of the flexion reflex in the rat,” Journal of Physiology, vol. 356, pp. 443–458, 1984. View at Google Scholar · View at Scopus
  36. R. Staud, M. E. Robinson, E. E. Weyl, and D. D. Price, “Pain variability in fibromyalgia is related to activity and rest: role of peripheral tissue impulse input,” Journal of Pain, vol. 11, pp. 1376–1383, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. R. Staud, S. Nagel, M. E. Robinson, and D. D. Price, “Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study,” Pain, vol. 145, no. 1-2, pp. 96–104, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. R. Ambalavanar, D. Dessem, A. Moutanni et al., “Muscle inflammation induces a rapid increase in calcitonin gene-related peptide (CGRP) mRNA that temporally relates to CGRP immunoreactivity and nociceptive behavior,” Neuroscience, vol. 143, no. 3, pp. 875–884, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. H. Imbe, R. Dubner, and K. Ren, “Masseteric inflammation-induced Fos protein expression in the trigeminal interpolaris/caudalis transition zone: contribution of somatosensory-vagal-adrenal integration,” Brain Research, vol. 845, no. 2, pp. 165–175, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Y. Ro, “Bite force measurement in awake rats: a behavioral model for persistent orofacial muscle pain and hyperalgesia,” Journal of Orofacial Pain, vol. 19, no. 2, pp. 159–167, 2005. View at Google Scholar · View at Scopus
  41. H. Sprott, S. Salemi, R. E. Gay et al., “Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibres,” Annals of the Rheumatic Diseases, vol. 63, no. 3, pp. 245–251, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. C. S. Stohler, C. J. Kowalski, and J. P. Lund, “Muscle pain inhibits cutaneous touch perception,” Pain, vol. 92, no. 3, pp. 327–333, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Svensson, L. Arendt-Nielsen, and L. Houe, “Muscle pain modulates mastication: an experimental study in humans,” Journal of Orofacial Pain, vol. 12, no. 1, pp. 7–16, 1998. View at Google Scholar · View at Scopus
  44. J. Y. Ro and N. F. Capra, “Modulation of jaw muscle spindle afferent activity following intramuscular injections with hypertonic saline,” Pain, vol. 92, no. 1-2, pp. 117–127, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. I. Tegeder, J. Zimmermann, S. T. Meller, and G. Geisslinger, “Release of algesic substances in human experimental muscle pain,” Inflammation Research, vol. 51, no. 8, pp. 393–402, 2002. View at Google Scholar · View at Scopus
  46. A. Iggo, “Non-myelinated afferent fibers from mammalian skeletal muscle,” Journal of Physiology, vol. 155, pp. 52–53, 1960. View at Google Scholar
  47. U. Hoheisel, J. Reinöhl, T. Unger, and S. Mense, “Acidic pH and capsaicin activate mechanosensitive group IV muscle receptors in the rat,” Pain, vol. 110, no. 1-2, pp. 149–157, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. K. A. Sluka, A. Kalra, and S. A. Moore, “Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia,” Muscle and Nerve, vol. 24, no. 1, pp. 37–46, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. K. A. Sluka, J. J. Rohlwing, R. A. Bussey, S. A. Eikenberry, and J. M. Wilken, “Chronic muscle pain induced by repeated acid injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists,” Journal of Pharmacology and Experimental Therapeutics, vol. 302, pp. 1146–1150, 2002. View at Google Scholar
  50. D. A. Skyba, E. W. King, and K. A. Sluka, “Effects of NMDA and non-NMDA ionotropic glutamate receptor antagonists on the development and maintenance of hyperalgesia induced by repeated intramuscular injection of acidic saline,” Pain, vol. 98, no. 1-2, pp. 69–78, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Ambalavanar, C. Yallampalli, U. Yallampalli, and D. Dessem, “Injection of adjuvant but not acidic saline into craniofacial muscle evokes nociceptive behaviors and neuropeptide expression,” Neuroscience, vol. 149, no. 3, pp. 650–659, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. M. Connor, L. A. Naves, and E. W. McCleskey, “Contrasting phenotypes of putative proprioceptive and nociceptive trigeminal neurons innervating jaw muscle in rat,” Molecular Pain, vol. 1, article 31, 2005. View at Publisher · View at Google Scholar · View at PubMed
  53. B. Diehl, U. Hoheisel, and S. Mense, “The influence of mechanical stimuli and of acetylsalicylic acid on the discharges of slowly conducting afferent units from normal and inflamed muscle in the rat,” Experimental Brain Research, vol. 92, no. 3, pp. 431–440, 1993. View at Google Scholar · View at Scopus
  54. L. J. Kehl, T. M. Trempe, and K. M. Hargreaves, “A new animal model for assessing mechanisms and management of muscle hyperalgesia,” Pain, vol. 85, no. 3, pp. 333–343, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. R. Radhakrishnan, S. A. Moore, and K. A. Sluka, “Unilateral carrageenan injection into muscle or joint induces chronic bilateral hyperalgesia in rats,” Pain, vol. 104, no. 3, pp. 567–577, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. K. Kaneyama, N. Segami, M. Nishimura, T. Suzuki, and J. Sato, “Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibular disorders,” British Journal of Oral and Maxillofacial Surgery, vol. 40, no. 5, pp. 418–423, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. K. Kaneyama, N. Segami, W. Sun, J. Sato, and K. Fujimura, “Analysis of tumor necrosis factor-α, interleukin-6, interleukin-1β, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 99, no. 3, pp. 276–284, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. S. Salemi, J. Rethage, U. Wollina et al., “Detection of interleukin 1β (IL-1β), IL-6, and tumor necrosis factor-α in skin of patients with fibromyalgia,” Journal of Rheumatology, vol. 30, no. 1, pp. 146–150, 2003. View at Google Scholar · View at Scopus
  59. D. A. Haas, O. Nakanishi, R. E. MacMillan, R. C. Jordan, and J. W. Hu, “Development of an orofacial model of acute inflammation in the rat,” Archives of Oral Biology, vol. 37, no. 5, pp. 417–422, 1992. View at Publisher · View at Google Scholar · View at Scopus
  60. X. M. Yu, B. J. Sessle, H. Vernon, and J. W. Hu, “Effects of inflammatory irritant application to the rat temporomandibular joint on jaw and neck muscle activity,” Pain, vol. 60, no. 2, pp. 143–149, 1995. View at Publisher · View at Google Scholar · View at Scopus
  61. A. C. Hartwig, S. I. Mathias, A. S. Law, and G. F. Gebhart, “Characterization and opioid modulation of inflammatory temporomandibular joint pain in the rat,” Journal of Oral and Maxillofacial Surgery, vol. 61, no. 11, pp. 1302–1309, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Y. Ro, A. Harriott, U. Crouse, and N. F. Capra, “Innocuous jaw movements increase c-fos expression in trigeminal sensory nuclei produced by masseter muscle inflammation,” Pain, vol. 104, no. 3, pp. 539–548, 2003. View at Publisher · View at Google Scholar
  63. M. Petersen and R. H. LaMotte, “Relationships between capsaicin sensitivity of mammalian sensory neurons, cell size and type of voltage gated Ca-currents,” Brain Research, vol. 561, no. 1, pp. 20–26, 1991. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Takeda, T. Tanimoto, M. Ito, M. Nasu, and S. Matsumoto, “Role of capsaicin-sensitive primary afferent inputs from the masseter muscle in the C spinal neurons responding to tooth-pulp stimulation in rats,” Experimental Brain Research, vol. 160, no. 1, pp. 107–117, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. D. M. Bautista, S. E. Jordt, T. Nikai et al., “TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents,” Cell, vol. 124, no. 6, pp. 1269–1282, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. K. Kobayashi, T. Fukuoka, K. Obata et al., “Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with Aδ/C-fibers and colocalization with Trk receptors,” Journal of Comparative Neurology, vol. 493, no. 4, pp. 596–606, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. D. A. Simone, P. Marchettini, G. Caputi, and J. L. Ochoa, “Identification of muscle afferents subserving sensation of deep pain in humans,” Journal of Neurophysiology, vol. 72, no. 2, pp. 883–889, 1994. View at Google Scholar · View at Scopus
  68. P. Marchettini, D. A. Simone, G. Caputi, and J. L. Ochoa, “Pain from excitation of identified muscle nociceptors in humans,” Brain Research, vol. 740, no. 1-2, pp. 109–116, 1996. View at Publisher · View at Google Scholar · View at Scopus
  69. B. E. Cairns, G. Gambarota, P. Svensson, L. Arendt-Nielsen, and C. B. Berde, “Glutamate-induced sensitization of rat masseter muscle fibers,” Neuroscience, vol. 109, no. 2, pp. 389–399, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Ernberg, T. Lundeberg, and S. Kopp, “Pain and allodynia/hyperalgesia induced by intramuscular injection of serotonin in patients with fibromyalgia and healthy individuals,” Pain, vol. 85, no. 1-2, pp. 31–39, 2000. View at Publisher · View at Google Scholar · View at Scopus
  71. S. Fock and S. Mense, “Excitatory effects of 5 hydroxytryptamine, histamine and potassium ions on muscular group IV afferent units: a comparison with bradykinin,” Brain Research, vol. 105, no. 3, pp. 459–469, 1976. View at Publisher · View at Google Scholar · View at Scopus
  72. U. Hoheisel, T. Unger, and S. Mense, “Excitatory and modulatory effects of inflammatory cytokines and neurotrophins on mechanosensitive group IV muscle afferents in the rat,” Pain, vol. 114, no. 1-2, pp. 168–176, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. H. Mørk, M. Ashina, L. Bendtsen, J. Olesen, and R. Jensen, “Experimental muscle pain and tenderness following infusion of endogenous substances in humans,” European Journal of Pain, vol. 7, no. 2, pp. 145–153, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. M. Franz and S. Mense, “Muscle receptors with group IV afferent fibres responding to application of bradykinin,” Brain Research, vol. 92, no. 3, pp. 369–383, 1975. View at Publisher · View at Google Scholar · View at Scopus
  75. S. Mense, “Sensitization of group IV muscle receptors to bradykinin by 5-hydroxytryptamine and prostaglandin E2,” Brain Research, vol. 225, no. 1, pp. 95–105, 1981. View at Publisher · View at Google Scholar · View at Scopus
  76. S. Schneider, D. Randoll, and M. Buchner, “Why do women have back pain more than men? A representative prevalence study in the Federal Republic of Germany,” Clinical Journal of Pain, vol. 22, no. 8, pp. 738–747, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  77. P. Svensson, B. E. Cairns, K. Wang, and L. Arendt-Nielsen, “Injection of nerve growth factor into human masseter muscle evokes long-lasting mechanical allodynia and hyperalgesia,” Pain, vol. 104, no. 1-2, pp. 241–247, 2003. View at Publisher · View at Google Scholar · View at Scopus
  78. W. Kessler, C. Kirchhoff, P. W. Reeh, and H. O. Handwerker, “Excitation of cutaneous afferent nerve endings in vitro by a combination of inflammatory mediators and conditioning effect of substance P,” Experimental Brain Research, vol. 91, no. 3, pp. 467–476, 1992. View at Google Scholar · View at Scopus
  79. R. M. Lovering and P. G. De Deyne, “Contractile function, sarcolemma integrity, and the loss of dystrophin after skeletal muscle eccentric contraction-induced injury,” American Journal of Physiology, vol. 286, no. 2, pp. C230–C238, 2004. View at Google Scholar · View at Scopus
  80. R. M. Lovering, M. Hakim, C. T. Moorman, and P. G. De Deyne, “The contribution of contractile pre-activation to loss of function after a single lengthening contraction,” Journal of Biomechanics, vol. 38, no. 7, pp. 1501–1507, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  81. D. Dessem, R. Ambalavanar, M. Evancho, A. Moutanni, C. Yallampalli, and G. Bai, “Eccentric muscle contraction and stretching evoke mechanical hyperalgesia and modulate CGRP and P2X3 expression in a functionally relevant manner,” Pain, vol. 149, no. 2, pp. 284–295, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  82. L. J. Beaton, M. A. Tarnopolsky, and S. M. Phillips, “Contraction-induced muscle damage in humans following calcium channel blocker administration,” Journal of Physiology, vol. 544, no. 3, pp. 849–859, 2002. View at Publisher · View at Google Scholar · View at Scopus
  83. K. Nosaka, M. Newton, and P. Sacco, “Delayed-onset muscle soreness does not reflect the magnitude of eccentric exercise-induced muscle damage,” Scandinavian Journal of Medicine and Science in Sports, vol. 12, no. 6, pp. 337–346, 2002. View at Google Scholar · View at Scopus
  84. F. X. Pizza, J. M. Peterson, J. H. Baas, and T. J. Koh, “Neutrophils contribute to muscle injury and impair its resolution after lengthening contractions in mice,” Journal of Physiology, vol. 562, no. 3, pp. 899–913, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  85. T. Taguchi, T. Matsuda, R. Tamura, J. Sato, and K. Mizumura, “Muscular mechanical hyperalgesia revealed by behavioural pain test and c-Fos expression in the spinal dorsal horn after eccentric contraction in rats,” Journal of Physiology, vol. 564, no. 1, pp. 259–268, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  86. T. J. McLoughlin, E. Mylona, T. A. Hornberger, K. A. Esser, and F. X. Pizza, “Inflammatory cells in rat skeletal muscle are elevated after electrically stimulated contractions,” Journal of Applied Physiology, vol. 94, no. 3, pp. 876–882, 2003. View at Google Scholar · View at Scopus
  87. R. L. Lieber, L. E. Thornell, and J. Fridén, “Muscle cytoskeletal disruption occurs within the first 15 min of cyclic eccentric contraction,” Journal of Applied Physiology, vol. 80, no. 1, pp. 278–284, 1996. View at Google Scholar · View at Scopus
  88. B. M. Lapointe, P. Frémont, and C. H. Côté, “Adaptation to lengthening contractions is independent of voluntary muscle recruitment but relies on inflammation,” American Journal of Physiology, vol. 282, no. 1, pp. R323–R329, 2002. View at Google Scholar · View at Scopus
  89. Y. W. Chen, M. J. Hubal, E. P. Hoffman, P. D. Thompson, and P. M. Clarkson, “Molecular responses of human muscle to eccentric exercise,” Journal of Applied Physiology, vol. 95, no. 6, pp. 2485–2494, 2003. View at Google Scholar · View at Scopus
  90. S. K. Tsivitse, T. J. McLoughlin, J. M. Peterson, E. Mylona, S. J. McGregor, and F. X. Pizza, “Downhill running in rats: influence on neutrophils, macrophages, and MyoD+ cells in skeletal muscle,” European Journal of Applied Physiology, vol. 90, no. 5-6, pp. 633–638, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  91. U. Proske and T. J. Allen, “Damage to skeletal muscle from eccentric exercise,” Exercise and Sport Sciences Reviews, vol. 33, no. 2, pp. 98–104, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. G. L. Warren, M. Summan, X. Gao, R. Chapman, T. Hulderman, and P. P. Simeonova, “Mechanisms of skeletal muscle injury and repair revealed by gene expression studies in mouse models,” Journal of Physiology, vol. 582, no. 2, pp. 825–841, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  93. L. Jensen, H. Pilegaard, P. D. Neufer, and Y. Hellsten, “Effect of acute exercise and exercise training on VEGF splice variants in human skeletal muscle,” American Journal of Physiology, vol. 287, no. 2, pp. R397–R402, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. S. Jonhagen, P. Ackermann, T. Saartok, and P. A. Renstrom, “Calcitonin gene related peptide and neuropeptide Y in skeletal muscle after eccentric exercise: a microdialysis study,” British Journal of Sports Medicine, vol. 40, no. 3, pp. 264–267, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  95. R. Kivelä, M. Silvennoinen, M. Lehti, S. Jalava, V. Vihko, and H. Kainulainen, “Exercise-induced expression of angiogenic growth factors in skeletal muscle and in capillaries of healthy and diabetic mice,” Cardiovascular Diabetology, vol. 7, article 13, 2008. View at Publisher · View at Google Scholar · View at PubMed
  96. R. B. Armstrong, R. W. Ogilvie, and J. A. Schwane, “Eccentric exercise-induced injury to rat skeletal muscle,” Journal of Applied Physiology Respiratory Environmental and Exercise Physiology, vol. 54, no. 1, pp. 80–93, 1983. View at Google Scholar · View at Scopus
  97. K. C. Darr and E. Schultz, “Exercise-induced satellite cell activation in growing and mature skeletal muscle,” Journal of Applied Physiology, vol. 63, no. 5, pp. 1816–1821, 1987. View at Google Scholar · View at Scopus
  98. G. K. Pavlath, D. Thaloor, T. A. Rando, M. Cheong, A. W. English, and B. Zheng, “Heterogeneity among muscle precursor cells in adult skeletal muscles with differing regenerative capacities,” Developmental Dynamics, vol. 212, no. 4, pp. 495–508, 1998. View at Publisher · View at Google Scholar · View at Scopus
  99. K. Shortreed, A. Johnston, and T. Hawke, “Satellite cells and muscle repair,” in Skeletal Muscle Damage and Repair, P. Tiidus, Ed., pp. 77–88, Human Kinetics, Champaign, Ill, USA, 2007. View at Google Scholar
  100. M. Hill, A. Wernig, and G. Goldspink, “Muscle satellite (stem) cell activation during local tissue injury and repair,” Journal of Anatomy, vol. 203, no. 1, pp. 89–99, 2003. View at Publisher · View at Google Scholar · View at Scopus
  101. T. Saka, B. Akova, Z. Yazici, U. Sekir, H. Gur, and Y. Ozarda, “Diference in the magnitude of muscle damage between elbow flexors and knee extensors eccentric exercises,” Journal of Sports Science and Medicine, vol. 8, pp. 107–115, 2009. View at Google Scholar
  102. A. Z. Jamurtas, V. Theocharis, T. Tofas et al., “Comparison between leg and arm eccentric exercises of the same relative intensity on indices of muscle damage,” European Journal of Applied Physiology, vol. 95, no. 2-3, pp. 179–185, 2005. View at Publisher · View at Google Scholar · View at PubMed
  103. L. Juhlin, H. Evers, and F. Broberg, “A lidocaine-prilocaine cream for superficial skin surgery and painful lesions,” Acta Dermato-Venereologica, vol. 60, no. 6, pp. 544–546, 1980. View at Google Scholar · View at Scopus
  104. R. Ambalavanar, M. Moritani, A. Moutanni, P. Gangula, C. Yallampalli, and D. Dessem, “Deep tissue inflammation upregulates neuropeptides and evokes nociceptive behaviors which are modulated by a neuropeptide antagonist,” Pain, vol. 120, no. 1-2, pp. 53–68, 2006. View at Publisher · View at Google Scholar · View at PubMed
  105. R. M. Lovering, J. A. Roche, R. J. Bloch, and P. G. De Deyne, “Recovery of function in skeletal muscle following 2 different contraction-induced injuries,” Archives of Physical Medicine and Rehabilitation, vol. 88, no. 5, pp. 617–625, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  106. D. Dessem, M. Moritani, and R. Ambalavanar, “Nociceptive craniofacial muscle primary afferent neurons synapse in both the rostral and caudal brain stem,” Journal of Neurophysiology, vol. 98, no. 1, pp. 214–223, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  107. M. Evancho, R. Ambalavanar, and D. Dessem, “Masseter muscle exhibits impaired repair following eccentric contraction of the muscle,” in Proceedings of the Annual Meeting of the American Association for Dental Research, Washington, DC, USA, 2006.
  108. T. A. McBride, F. A. Gorin, and R. C. Carlsen, “Prolonged recovery and reduced adaptation in aged rat muscle following eccentric exercise,” Mechanisms of Ageing and Development, vol. 83, no. 3, pp. 185–200, 1995. View at Publisher · View at Google Scholar · View at Scopus
  109. S. V. Brooks, E. Zerba, and J. A. Faulkner, “Injury to muscle fibres after single stretches of passive and maximally stimulated muscles in mice,” Journal of Physiology, vol. 488, no. 2, pp. 459–469, 1995. View at Google Scholar · View at Scopus
  110. J. A. Faulkner, S. V. Brooks, and J. A. Opiteck, “Injury to skeletal muscle fibers during contractions: conditions of occurrence and prevention,” Physical Therapy, vol. 73, no. 12, pp. 911–921, 1993. View at Google Scholar · View at Scopus
  111. G. L. Warren, D. A. Lowe, and R. B. Armstrong, “Measurement tools used in the study of eccentric contraction-induced injury,” Sports Medicine, vol. 27, no. 1, pp. 43–59, 1999. View at Publisher · View at Google Scholar · View at Scopus
  112. D. J. Newham, D. A. Jones, and P. M. Clarkson, “Repeated high-force eccentric exercise: effects on muscle pain and damage,” Journal of Applied Physiology, vol. 63, no. 4, pp. 1381–1386, 1987. View at Google Scholar · View at Scopus
  113. P. Sacco and D. A. Jones, “The protective effect of damaging eccentric exercise against repeated bouts of exercise in the mouse tibialis anterior muscle,” Experimental physiology, vol. 77, no. 5, pp. 757–760, 1992. View at Google Scholar · View at Scopus
  114. F. X. Pizza, B. H. Davis, S. D. Henrickson et al., “Adaptation to eccentric exercise: effect on CD64 and CD 11b/CD 18 expression,” Journal of Applied Physiology, vol. 80, no. 1, pp. 47–55, 1996. View at Google Scholar · View at Scopus
  115. A. J. McKune, L. L. Smith, S. J. Semple, B. Mokethwa, and A. A. Wadee, “Immunoglobulin responses to a repeated bout of downhill running,” British Journal of Sports Medicine, vol. 40, no. 10, pp. 844–849, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  116. T. C. Chen, H. L. Chen, M. J. Lin, C. J. Wu, and K. Nosaka, “Muscle damage responses of the elbow flexors to four maximal eccentric exercise bouts performed every 4 weeks,” European Journal of Applied Physiology, vol. 106, no. 2, pp. 267–275, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  117. G. Paulsen, F. Lauritzen, M. L. Bayer et al., “Subcellular movement and expression of HSP27, alphaB-crystallin, and HSP70 after two bouts of eccentric exercise in humans,” Journal of Applied Physiology, vol. 107, pp. 570–582, 2009. View at Google Scholar
  118. M. P. McHugh, “Recent advances in the understanding of the repeated bout effect: the protective effect against muscle damage from a single bout of eccentric exercise,” Scandinavian Journal of Medicine and Science in Sports, vol. 13, no. 2, pp. 88–97, 2003. View at Publisher · View at Google Scholar
  119. R. Lynn and D. L. Morgan, “Decline running produces more sarcomeres in rat vastus intermedius muscle fibers than does incline running,” Journal of Applied Physiology, vol. 77, no. 3, pp. 1439–1444, 1994. View at Google Scholar · View at Scopus
  120. R. Lynn, J. A. Talbot, and D. L. Morgan, “Differences in rat skeletal muscles after incline and decline running,” Journal of Applied Physiology, vol. 85, no. 1, pp. 98–104, 1998. View at Google Scholar · View at Scopus
  121. C. L. Brockett, D. L. Morgan, and U. Proske, “Human hamstring muscles adapt to eccentric exercise by changing optimum length,” Medicine and Science in Sports and Exercise, vol. 33, no. 5, pp. 783–790, 2001. View at Google Scholar · View at Scopus
  122. C. P. Ingalls, G. L. Warren, J. H. Williams, C. W. Ward, and R. B. Armstrong, “E-C coupling failure in mouse EDL muscle after in vivo eccentric contractions,” Journal of Applied Physiology, vol. 85, no. 1, pp. 58–67, 1998. View at Google Scholar · View at Scopus
  123. F. X. Pizza, T. J. Koh, S. J. McGregor, and S. V. Brooks, “Muscle inflammatory cells after passive stretches, isometric contractions, and lengthening contractions,” Journal of Applied Physiology, vol. 92, no. 5, pp. 1873–1878, 2002. View at Google Scholar
  124. M. J. Hubal, T. C. Chen, P. D. Thompson, and P. M. Clarkson, “Inflammatory gene changes associated with the repeated-bout effect,” American Journal of Physiology, vol. 294, no. 5, pp. R1628–R1637, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  125. T. M. Lehti, R. Kalliokoski, and J. Komulainen, “Repeated bout effect on the cytoskeletal proteins titin, desmin, and dystrophin in rat skeletal muscle,” Journal of Muscle Research and Cell Motility, vol. 28, no. 1, pp. 39–47, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  126. T. J. Koh and S. V. Brooks, “Lengthening contractions are not required to induce protection from contraction-induced muscle injury,” American Journal of Physiology, vol. 281, no. 1, pp. R155–R161, 2001. View at Google Scholar · View at Scopus
  127. T. E. Reich, S. L. Lindstedt, P. C. LaStayo, and D. J. Pierotti, “Is the spring quality of muscle plastic?” American Journal of Physiology, vol. 278, no. 6, pp. R1661–R1666, 2000. View at Google Scholar · View at Scopus
  128. M. P. McHugh, D. A. J. Connolly, R. G. Eston, I. J. Kremenic, S. J. Nicholas, and G. W. Gleim, “The role of passive muscle stiffness in symptoms of exercise-induced muscle damage,” American Journal of Sports Medicine, vol. 27, no. 5, pp. 594–599, 1999. View at Google Scholar · View at Scopus
  129. T. Marqueste, B. Giannesini, Y. L. Fur, P. J. Cozzone, and D. Bendahan, “Comparative MRI analysis of T2 changes associated with single and repeated bouts of downhill running leading to eccentric-induced muscle damage,” Journal of Applied Physiology, vol. 105, no. 1, pp. 299–307, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  130. A. G. Glaros and E. Burton, “Parafunctional clenching, pain, and effort in temporomandibular disorders,” Journal of Behavioral Medicine, vol. 27, no. 1, pp. 91–100, 2004. View at Publisher · View at Google Scholar · View at Scopus
  131. A. G. Glaros, K. Williams, and L. Lausten, “The role of parafunctions, emotions and stress in predicting facial pain,” Journal of the American Dental Association, vol. 136, no. 4, pp. 451–458, 2005. View at Google Scholar · View at Scopus
  132. T. Arima, P. Svensson, and L. Arendt-Nielsen, “Experimental grinding in healthy subjects: a model for postexercise jaw muscle soreness?” Journal of Orofacial Pain, vol. 13, no. 2, pp. 104–114, 1999. View at Google Scholar · View at Scopus
  133. L. V. Christensen, “Facial pain and internal pressure of masseter muscle in experimental bruxism in man,” Archives of Oral Biology, vol. 16, no. 9, pp. 1021–1031, 1971. View at Google Scholar · View at Scopus
  134. J. F. Bowley and E. N. Gale, “Experimental masticatory muscle pain,” Journal of Dental Research, vol. 66, no. 12, pp. 1765–1769, 1987. View at Google Scholar · View at Scopus
  135. G. T. Clark, R. W. Jow, and J. J. Lee, “Jaw pain and stiffness levels after repeated maximum voluntary clenching,” Journal of dental research, vol. 68, no. 1, pp. 69–71, 1989. View at Google Scholar · View at Scopus
  136. P. Svensson, L. Houe, and L. Arendt-Nielsen, “Effect of systemic versus topical nonsteroidal anti-inflammatory drugs on postexercise jaw-muscle soreness: a placebo-controlled study,” Journal of Orofacial Pain, vol. 11, no. 4, pp. 353–362, 1997. View at Google Scholar · View at Scopus
  137. D. J. Newham, G. McPhail, K. R. Mills, and R. H. Edwards, “Ultrastructural changes after concentric and eccentric contractions of human muscle,” Journal of the Neurological Sciences, vol. 61, no. 1, pp. 109–122, 1983. View at Publisher · View at Google Scholar
  138. C. Wiesmann, Y. A. Muller, and A. M. De Vos, “Ligand-binding sites in Ig-like domains of receptor tyrosine kinases,” Journal of Molecular Medicine, vol. 78, no. 5, pp. 247–260, 2000. View at Google Scholar · View at Scopus
  139. Y. Xie, M. A. Tisi, T. T. Yeo, and F. M. Longo, “Nerve growth factor (NGF) loop 4 dimeric mimetics activate ERK and AKT and promote NGF-like neurotrophic effects,” Journal of Biological Chemistry, vol. 275, no. 38, pp. 29868–29874, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  140. P. J. Dyck, S. Peroutka, C. Rask et al., “Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans,” Neurology, vol. 48, no. 2, pp. 501–505, 1997. View at Google Scholar · View at Scopus
  141. K. D. Wild, D. Bian, D. Zhu et al., “Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance,” Journal of Pharmacology and Experimental Therapeutics, vol. 322, no. 1, pp. 282–287, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  142. C. J. Woolf, B. Safieh-Garabedian, Q. P. Ma, P. Crilly, and J. Winter, “Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity,” Neuroscience, vol. 62, pp. 327–331, 1994. View at Google Scholar
  143. C. J. Woolf, Q. P. Ma, A. Allchorne, and S. Poole, “Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation,” Journal of Neuroscience, vol. 16, no. 8, pp. 2716–2723, 1996. View at Google Scholar · View at Scopus
  144. L. Kehl, A. Velly, D. Besspiata, A. Jackson, P. Lenton, and E. Schiffman, “Characteristics of muscle pain are associated with nerve growth factor content in human muscle,” Society for Neuroscience Abstracts, 2008, abstract 174.8. View at Google Scholar
  145. D. Dessem, A. Mouotani, R. Cleiman et al., “Sex differences in movement-induced muscle pain,” Society for Neuroscience Abstracts, 2010, abstract 81.7. View at Google Scholar
  146. S. Murase, E. Terazawa, F. Queme et al., “Bradykinin and nerve growth factor play pivotal roles in muscular mechanical hyperalgesia after exercise (d elayed-onset muscle soreness),” Journal of Neuroscience, vol. 30, no. 10, pp. 3752–3761, 2010. View at Publisher · View at Google Scholar · View at PubMed
  147. C. Wu, M. A. Erickson, J. Xu, K. D. Wild, and T. J. Brennan, “Expression profile of nerve growth factor after muscle incision in the rat,” Anesthesiology, vol. 110, no. 1, pp. 140–149, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  148. B. G. Petty, D. R. Cornblath, B. T. Adornato et al., “The effect of systemically administered recombinant human nerve growth factor in healthy human subjects,” Annals of Neurology, vol. 36, no. 2, pp. 244–246, 1994. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  149. T. Taguchi, J. Sato, and K. Mizumura, “Augmented mechanical response of muscle thin-fiber sensory receptors recorded from rat muscle-nerve preparations in vitro after eccentric contraction,” Journal of Neurophysiology, vol. 94, no. 4, pp. 2822–2831, 2005. View at Publisher · View at Google Scholar · View at PubMed
  150. P. Toti, M. Villanova, R. Vatti et al., “Nerve growth factor expression in human dystrophic muscles,” Muscle and Nerve, vol. 27, no. 3, pp. 370–373, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  151. R. A. Murphy, R. H. Singer, J. D. Saide et al., “Synthesis and secretion of a high molecular weight form of nerve growth factor by skeletal muscle cells in culture,” Proceedings of the National Academy of Sciences of the United States of America, vol. 74, no. 10, pp. 4496–4500, 1977. View at Google Scholar
  152. E. Di Marco, P. C. Marchisio, S. Bondanza, A. T. Franzi, R. Cancedda, and M. De Luca, “Growth-regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes,” Journal of Biological Chemistry, vol. 266, no. 32, pp. 21718–21722, 1991. View at Google Scholar · View at Scopus
  153. C. Olgart and N. Frossard, “Human lung fibroblasts secrete nerve growth factor: effect of inflammatory cytokines and glucocorticoids,” European Respiratory Journal, vol. 18, no. 1, pp. 115–121, 2001. View at Publisher · View at Google Scholar · View at Scopus
  154. A. Leon, A. Buriani, R. D. Toso et al., “Mast cells synthesize, store, and release nerve growth factor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 9, pp. 3739–3743, 1994. View at Google Scholar · View at Scopus
  155. G. Nilsson, K. Forsberg-Nilsson, Z. Xiang, F. Hallböök, K. Nilsson, and D. D. Metcalfe, “Human mast cells express functional TrkA and are a source of nerve growth factor,” European Journal of Immunology, vol. 27, no. 9, pp. 2295–2301, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  156. R. D. P. Stanzel, S. Lourenssen, and M. G. Blennerhassett, “Inflammation causes expression of NGF in epithelial cells of the rat colon,” Experimental Neurology, vol. 211, no. 1, pp. 203–213, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  157. M. D'Arco, R. Giniatullin, M. Simonetti et al., “Neutralization of nerve growth factor induces plasticity of ATP-sensitive P2X3 receptors of nociceptive trigeminal ganglion neurons,” Journal of Neuroscience, vol. 27, no. 31, pp. 8190–8201, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  158. S. C. Supowit, H. Zhao, and D. J. DiPette, “Nerve growth factor enhances calcitonin gene-related peptide expression in the spontaneously hypertensive rat,” Hypertension, vol. 37, no. 2, pp. 728–732, 2001. View at Google Scholar · View at Scopus
  159. M. S. Ramer, E. J. Bradbury, and S. B. McMahon, “Nerve growth factor induces P2X3 expression in sensory neurons,” Journal of Neurochemistry, vol. 77, no. 3, pp. 864–875, 2001. View at Publisher · View at Google Scholar · View at Scopus
  160. J. Xing, J. Lu, and J. Li, “Contribution of nerve growth factor to augmented TRPV1 responses of muscle sensory neurons by femoral artery occlusion,” American Journal of Physiology, vol. 296, no. 5, pp. H1380–H1387, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  161. S. Orita, S. Ohtori, M. Nagata et al., “Inhibiting nerve growth factor or its receptors downregulates calcitonin gene-related peptide expression in rat lumbar dorsal root ganglia innervating injured intervertebral discs,” Journal of Orthopaedic Research, vol. 28, no. 12, pp. 1614–1620, 2010. View at Publisher · View at Google Scholar · View at PubMed
  162. P. M. Dunn, Y. U. Zhong, and G. Burnstock, “P2X receptors in peripheral neurons,” Progress in Neurobiology, vol. 65, no. 2, pp. 107–134, 2001. View at Publisher · View at Google Scholar · View at Scopus
  163. B. S. Khakh and R. A. North, “P2X receptors as cell-surface ATP sensors in health and disease,” Nature, vol. 442, no. 7102, pp. 527–532, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  164. J. Reinöhl, U. Hoheisel, T. Unger, and S. Mense, “Adenosine triphosphate as a stimulant for nociceptive and non-nociceptive muscle group IV receptors in the rat,” Neuroscience Letters, vol. 338, no. 1, pp. 25–28, 2003. View at Publisher · View at Google Scholar · View at Scopus
  165. M. Shinoda, N. Ozaki, and Y. Sugiura, “Involvement of ATP and its receptors on nociception in rat model of masseter muscle pain,” Pain, vol. 134, no. 1-2, pp. 148–157, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  166. R. A. North, “The P2X3 subunit: a molecular target in pain therapeutics,” Current Opinion in Investigational Drugs, vol. 4, no. 7, pp. 833–840, 2003. View at Google Scholar · View at Scopus
  167. R. Ambalavanar and D. Dessem, “Emerging peripheral receptor targets for deep-tissue craniofacial pain therapies,” Journal of Dental Research, vol. 88, no. 3, pp. 201–211, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  168. R. Ambalavanar, M. Moritani, and D. Dessem, “Trigeminal P2X3 receptor expression differs from dorsal root ganglion and is modulated by deep tissue inflammation,” Pain, vol. 117, no. 3, pp. 280–291, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  169. S. P. Cook and E. W. McCleskey, “Cell damage excites nociceptors through release of cytosolic ATP,” Pain, vol. 95, no. 1-2, pp. 41–47, 2002. View at Publisher · View at Google Scholar · View at Scopus
  170. L. C. Stewart, R. Deslauriers, and V. V. Kupriyanov, “Relationships between cytosolic [ATP], [ATP]/[ADP] and ionic fluxes in the perfused rat heart: a 31P, 23Na and 87Rb NMR study,” Journal of Molecular and Cellular Cardiology, vol. 26, no. 10, pp. 1377–1392, 1994. View at Google Scholar
  171. R. Gamse, M. Posch, A. Saria, and G. Jancsó, “Several mediators appear to interact in neurogenic inflammation,” Acta Physiologica Hungarica, vol. 69, no. 3-4, pp. 343–354, 1987. View at Google Scholar · View at Scopus
  172. R. L. Nahin and M. R. Byers, “Adjuvant-induced inflammation of rat paw is associated with altered calcitonin gene-related peptide immunoreactivity within cell bodies and peripheral endings of primary afferent neurons,” Journal of Comparative Neurology, vol. 349, no. 3, pp. 475–485, 1994. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  173. C. Woolf and Z. Wiesenfeld-Hallin, “Substance P and calcitonin gene-related peptide synergistically modulate the gain of the nociceptive flexor withdrawal reflex in the rat,” Neuroscience Letters, vol. 66, no. 2, pp. 226–230, 1986. View at Google Scholar · View at Scopus
  174. L. Zhang, A. O. Hoff, S. J. Wimalawansa, G. J. Cote, R. F. Gagel, and K. N. Westlund, “Arthritic calcitonin/α calcitonin gene-related peptide knockout mice have reduced nociceptive hypersensitivity,” Pain, vol. 89, no. 2-3, pp. 265–273, 2001. View at Publisher · View at Google Scholar · View at Scopus
  175. B. Hutchins, R. Spears, R. J. Hinton, and R. P. Harper, “Calcitonin gene-related peptide and substance P immunoreactivity in rat trigeminal ganglia and brainstem following adjuvant-induced inflammation of the temporomandibular joint,” Archives of Oral Biology, vol. 45, no. 4, pp. 335–345, 2000. View at Publisher · View at Google Scholar · View at Scopus
  176. A. Ohlen, L. Lindbom, W. Staines et al., “Substance P and calcitonin gene-related peptide: immunohistochemical localisation and microvascular effects in rabbit skeletal muscle,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 336, no. 1, pp. 87–93, 1987. View at Google Scholar
  177. S. D. Brain, J. R. Tippins, and H. R. Morris, “Potent vasodilator activity of calcitonin gene-related peptide in human skin,” Journal of Investigative Dermatology, vol. 87, no. 4, pp. 533–536, 1986. View at Google Scholar
  178. D. G. Bulling, D. Kelly, S. Bond, D. S. McQueen, and J. R. Seckl, “Adjuvant-induced joint inflammation causes very rapid transcription of beta-preprotachykinin and alpha-CGRP genes in innervating sensory ganglia,” Journal of Neurochemistry, vol. 77, no. 2, pp. 372–382, 2001. View at Google Scholar
  179. E. J. Bradbury, G. Burnstock, and S. B. McMahon, “The expression of P2X3 purinoreceptors in sensory neurons: effects of axotomy and glial-derived neurotrophic factor,” Molecular and Cellular Neurosciences, vol. 12, no. 4-5, pp. 256–268, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  180. J. C. Petruska, J. Napaporn, R. D. Johnson, J. G. Gu, and B. Y. Cooper, “Subclassified acutely dissociated cells of rat DRG: histochemistry and patterns of capsaicin-, proton-, and ATP-activated currents,” Journal of Neurophysiology, vol. 84, no. 5, pp. 2365–2379, 2000. View at Google Scholar · View at Scopus
  181. T. J. Price, M. D. Louria, D. Candelario-Soto et al., “Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretion,” BMC Neuroscience, vol. 6, article 4, 2005. View at Publisher · View at Google Scholar · View at PubMed
  182. M. Simonetti, A. Fabbro, M. D'Arco et al., “Comparison of P2X and TRPV1 receptors in ganglia or primary culture of trigeminal neurons and their modulation by NGF or serotonin,” Molecular Pain, vol. 2, article 11, 2006. View at Google Scholar
  183. H. Kanehira, A. Agariguchi, H. Kato, S. Yoshimine, and H. Inoue, “Association between stress and temporomandibular disorder,” Nihon Hotetsu Shika Gakkai Zasshi, vol. 52, no. 3, pp. 375–380, 2008. View at Publisher · View at Google Scholar · View at Scopus
  184. F. Licini, A. Nojelli, M. Segù, and V. Collesano, “Role of psychosocial factors in the etiology of temporomandibular disorders: relevance of a biaxial diagnosis,” Minerva Stomatologica, vol. 58, no. 11-12, pp. 557–566, 2009. View at Google Scholar · View at Scopus
  185. A. M. Nilsson and L. Dahlstrm, “Perceived symptoms of psychological distress and salivary cortisol levels in young women with muscular or disk-related temporomandibular disorders,” Acta Odontologica Scandinavica, vol. 68, no. 5, pp. 284–288, 2010. View at Publisher · View at Google Scholar · View at PubMed
  186. M. Martínez-Lavín, A. G. Hermosillo, M. Rosas, and M. E. Soto, “Circadian studies of autonomic nervous balance in patients with fibromyalgia: a heart rate variability analysis,” Arthritis and Rheumatism, vol. 41, no. 11, pp. 1966–1971, 1998. View at Publisher · View at Google Scholar · View at Scopus
  187. J. E. Schmidt and C. R. Carlson, “A controlled comparison of emotional reactivity and physiological response in masticatory muscle pain patients,” Journal of Orofacial Pain, vol. 23, no. 3, pp. 230–242, 2009. View at Google Scholar · View at Scopus
  188. K. Mizurma, T. Taguchi, and T. Nasu, “Persistent muscular mechanical hyperalgesia induced by lengthening contraction followed by repetitive stress,” Journal of Musculoskeletal Pain, vol. 15, article 64, 2007. View at Google Scholar
  189. R. Staud, R. C. Cannon, A. P. Mauderli, M. E. Robinson, D. D. Price, and C. J. Vierck Jr., “Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome,” Pain, vol. 102, no. 1-2, pp. 87–95, 2003. View at Publisher · View at Google Scholar · View at Scopus
  190. M. F. Jarvis, E. C. Burgard, S. McGaraughty et al., “A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X3 receptors, reduces chronic inflammatory and neuropathic pain in the rat,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 26, pp. 17179–17184, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  191. F. F. Hefti, A. Rosenthal, P. A. Walicke et al., “Novel class of pain drugs based on antagonism of NGF,” Trends in Pharmacological Sciences, vol. 27, no. 2, pp. 85–91, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  192. J. J. Watson, S. J. Allen, and D. Dawbarn, “Targeting nerve growth factor in pain: what is the therapeutic potential?” BioDrugs, vol. 22, no. 6, pp. 349–359, 2008. View at Publisher · View at Google Scholar · View at Scopus